August 2024

ADHC Announces Corporate Restructuring Del Mar, California–(Newsfile Corp. – August 29, 2024) American Diversified Holdings Corporation (OTC Pink: ADHC) has made a significant announcement today regarding the completion of a comprehensive overhaul of the company’s balance sheet and capitalization structure. This comes on the heels of the recent $2.73 million debt cancellation and signals a…

Phio Pharmaceuticals Corp. to Present at the Virtual Non-Deal Roadshow Series Presentation Details Thursday, September 5, 2024 Marlborough, Massachusetts–(Newsfile Corp. – August 29, 2024) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, announced…

Allison Transmission and Cummins Inc. Collaborate on Electrified Propulsion Testing Indianapolis, Aug. 29, 2024 /PRNewswire/ — A Partnership for Innovation Allison Transmission, a renowned leader in fully automatic transmissions and electrified propulsion systems, has recently announced a collaboration with Cummins Inc., a global powerhouse in power solutions. This partnership involves Cummins utilizing Allison’s cutting-edge Vehicle…

Strict Cost Control Measures in Place at Northern Graphite Corporation Preserving Working Capital and Bolstering Balance Sheet Northern Graphite Corporation has recently implemented strict cost control measures in order to preserve working capital and bolster their balance sheet. The company’s focus on cost efficiency is aimed at ensuring sustainable growth and long-term success in the…

Share Repurchase Program: A Sign of Confidence in BOSS Zhipin August 29, 2024 KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), today announced that the Company’s board of directors has authorized a new share repurchase program effective from August 29, 2024 for a 12-month period, under which the Company may additionally repurchase…

Ensysce Biosciences, Inc. Raises Funds for Innovative Pain Relief Solutions Exciting News from Ensysce Ensysce Biosciences, Inc. has recently made headlines with their announcement of entering into definitive agreements that will provide the company with $5 million in gross proceeds. This funding will support their ongoing efforts to develop innovative solutions for severe pain relief,…